COVID-19 Convalescent Patient Antibody, IgG Fraction
SARS-CoV-2 is the novel coronavirus that causes CoronaVirus Disease 2019 (COVID-19). This IgG fraction is purified by immobilized Protein A from pooled sera collected from convalescent COVID-19 patients. Serum was collected at least two weeks post symptom development from patients with positive COVID-19 PCR and serology tests. This antibody preparation is strongly positive in the Molecular Innovations SARS-CoV-2 IgG Seroconversion ELISA Kit and can be useful as a positive control or calibrator in a variety of serological assays. Add PBS to desired volume, aliquot and freeze unused portion.